Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00118664 · ClinicalTrials.gov registry record
Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Completed
- Registry status
- 86
- Enrollment target
NCT00118664 is a clinical trial that has completed, run by Children's Healthcare of Atlanta. The registered enrollment target is 86 participants.
The verdict
NCT00118664 has completed, sponsored by Children's Healthcare of Atlanta.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
The purpose of this study is to learn how blood clotting substances respond in children with septic shock, low platelet counts, and multiple organ failure (MOF) treated at different institutions. Multiple organ failure can be related to an infection producing "septic shock," in which substances released in the blood cause poor blood flow to the organs. The number of platelets circulating in your child's blood stream is also decreased (this is called "thrombocytopenia") as a result of this condition. Research has shown that certain substances in the part of the blood known as plasma (the clear liquid part of the blood not including the red blood cells but holding blood clotting factors) can cause the organs to work poorly. The investigators would like to compare these blood responses in children with this condition, receiving a variety of different treatments, for multiple organ failure in other medical centers around the world. The investigators hope to enroll 80 patients into the study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2005-05 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00118664
The ClinicalTrials.gov registry entry for NCT00118664 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Healthcare of Atlanta, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00118664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00118664 about?
NCT00118664 is a clinical study titled "Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children". The purpose of this study is to learn how blood clotting substances respond in children with septic shock, low platelet counts, and multiple organ failure (MOF) treated at different institutions. Multiple organ failure can be related to an infection producing "septic shock," in which substances rel...
What is the current status of trial NCT00118664?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2005-05. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT00118664?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.